Health Boards
Sat-13-08-2022, 10:33 AM
Update: The U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis.
|
Tremfya going after psoriatic arthritis
|
Sun-14-08-2022, 18:18 PM
To be honest, non of the IL23s seem to work for the back, at least not for me.
 (Sun-14-08-2022, 18:18 PM)mataribot Wrote: To be honest, non of the IL23s seem to work for the back, at least not for me. I can imagine that. Personally I have the idea that the IL23’s are more related to psoriasis and that the IL17’s and IL17A’s are more related to Psoriatic Arthritis. Considering all the examples over here on psoriasisclub. |
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Tremfya vs Stelara Italian study | Fred | 2 | 90 |
Yesterday, 12:39 PM Last Post: Fred |
|
|
Skyrizi results for psoriatic arthritis | Fred | 3 | 845 |
Fri-05-08-2022, 11:09 AM Last Post: Fred |
|
|
Tremfya super response study | Fred | 4 | 1,451 |
Thu-04-08-2022, 19:34 PM Last Post: mataribot |
|
|
Metabolic syndrome more common in patients with psoriatic arthritis | Fred | 6 | 3,248 |
Fri-01-07-2022, 20:51 PM Last Post: Caroline |
|
|
One year Tremfya evaluation of efficacy & safety | Fred | 1 | 845 |
Fri-03-06-2022, 13:09 PM Last Post: Forest Walker |
Users browsing this thread: 1 Guest(s)